AAAAAA
Results: 26-49/49
Authors:
Oberg, K
Citation: K. Oberg, Interferon in the management of neuroendocrine GEP-tumors - A review, DIGESTION, 62, 2000, pp. 92-97
Authors:
Eriksson, B
Oberg, K
Citation: B. Eriksson et K. Oberg, Neuroendocrine tumours of the pancreas, BR J SURG, 87(2), 2000, pp. 129-131
Authors:
Janson, ET
Oberg, K
Citation: Et. Janson et K. Oberg, Somatostatin receptor ligands and their use in the treatment of endocrine disorders, CUR PHARM D, 5(9), 1999, pp. 693-705
Authors:
Oberg, K
Janson, ET
Eriksson, B
Citation: K. Oberg et al., Tumour markers in neuroendocrine tumours, ITAL J GAST, 31, 1999, pp. S160-S162
Authors:
Eriksson, B
Orlefors, H
Sundin, A
Skogseid, B
Langstrom, B
Bergstrom, M
Oberg, K
Citation: B. Eriksson et al., Positron emission tomography in neuroendocrine tumours, ITAL J GAST, 31, 1999, pp. S167-S171
Authors:
Janson, ET
Kalkner, KM
Eriksson, B
Westlin, JE
Oberg, K
Citation: Et. Janson et al., Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors, NUCL MED BI, 26(8), 1999, pp. 877-882
Authors:
Oberg, K
Citation: K. Oberg, Untitled, ANN ONCOL, 10, 1999, pp. S1-S1
Authors:
Oberg, K
Citation: K. Oberg, Neuroendocrine gastrointestinal tumors - a condensed overview of diagnosisand treatment, ANN ONCOL, 10, 1999, pp. S3-S8
Authors:
Eriksson, B
Oberg, K
Citation: B. Eriksson et K. Oberg, Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook, ANN ONCOL, 10, 1999, pp. S31-S38
Authors:
Larsson, G
Sjoden, PO
Oberg, K
von Essen, L
Citation: G. Larsson et al., Importance-satisfaction discrepancies are associated with health-related quality of life in five-year survivors of endocrine gastrointestinal tumours, ANN ONCOL, 10(11), 1999, pp. 1321-1327
Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease
Authors:
Makrides, C
Theodorsson, E
Akerstrom, G
Oberg, K
Knutson, L
Citation: C. Makrides et al., Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease, J GASTR HEP, 14(5), 1999, pp. 500-507
Authors:
Zhou, Y
Wang, S
Gobl, A
Oberg, K
Citation: Y. Zhou et al., Inhibition of CDK2, CDK4 and cyclin E and increased expression of p27Kip1 during treatment with interferon-alpha in carcinoid tumor cells, J BIOL REG, 13(4), 1999, pp. 207-215
Authors:
Janson, ET
Eriksson, B
Oberg, K
Skogseid, B
Ohrvall, U
Nilsson, S
Westlin, JE
Citation: Et. Janson et al., Treatment with high dose [In-111-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors - Evaluation of therapeutic and toxic effects, ACTA ONCOL, 38(3), 1999, pp. 373-377
Authors:
Lukinius, A
Ohrvall, U
Westlin, JE
Oberg, K
Janson, ET
Citation: A. Lukinius et al., In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex, ACTA ONCOL, 38(3), 1999, pp. 383-387
Authors:
Gobl, AE
Berg, M
Lopez-Egido, JR
Oberg, K
Skogseid, B
Westin, G
Citation: Ae. Gobl et al., Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism, BBA-GENE ST, 1447(1), 1999, pp. 51-56
Authors:
Granberg, D
Stridsberg, M
Seensalu, R
Eriksson, B
Lundqvist, G
Oberg, K
Skogseid, B
Citation: D. Granberg et al., Plasma chromogranin A in patients with multiple endocrine neoplasia type 1, J CLIN END, 84(8), 1999, pp. 2712-2717
Authors:
Granberg, D
Wilander, E
Oberg, K
Skogseid, B
Citation: D. Granberg et al., Decreased survival in patients with CD44-negative typical bronchial carcinoid tumors, INT J CANC, 84(5), 1999, pp. 484-488
Authors:
Stalberg, P
Wang, S
Larsson, C
Weber, C
Oberg, K
Gobl, A
Skogseid, B
Citation: P. Stalberg et al., Suppression of the neoplastic phenotype by transfection of phospholipase Cbeta 3 to neuroendocrine tumor cells, FEBS LETTER, 450(3), 1999, pp. 210-216
Authors:
Toren, A
Oberg, K
Citation: A. Toren et K. Oberg, Maximum isometric trunk muscle strength and activity at trunk axial rotation during sitting, APPL ERGON, 30(6), 1999, pp. 515-525
Authors:
Zhou, U
Gobl, A
Wang, S
Jacobsen, MB
Janson, ET
Haines, GK
Radosevich, JA
Oberg, K
Citation: U. Zhou et al., Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours, EUR J CANC, 34(13), 1998, pp. 2046-2052
Authors:
Oberg, K
Citation: K. Oberg, Gastric neuroendocrine cells and secretory products, YALE J BIOL, 71(3-4), 1998, pp. 149-154
Authors:
Hellman, P
Skogseid, B
Oberg, K
Juhlin, C
Akerstrom, G
Rastad, J
Citation: P. Hellman et al., Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1, SURGERY, 124(6), 1998, pp. 993-999
Authors:
Wang, S
Gebre-Medhin, S
Betsholtz, C
Stalberg, P
Zhou, YH
Larsson, C
Weber, G
Feinstein, R
Oberg, K
Gobl, A
Skogseid, B
Citation: S. Wang et al., Targeted disruption of the mouse phospholipase C beta 3 gene results in early embryonic lethality, FEBS LETTER, 441(2), 1998, pp. 261-265
Authors:
Oberg, K
Citation: K. Oberg, Medical treatment of malignant neuroendocrine tumors, ANN ENDOCR, 59, 1998, pp. 46-47